Working visit of the Minister of Industry and Trade of the Russian Federation to Kurgan

Working visit of the Minister of Industry and Trade of the Russian Federation to Kurgan Velpharm LLC took part in the exhibition of the leading industrial enterprises of the city of Kurgan, organized on the basis of NPO Kurganpribor, within the framework of the working visit of the Minister of Industry and Trade of the Russian Federation, Denis Manturov.
Accompanied by the Plenipotentiary Representative of the President of the Russian Federation in the Urals Federal District Vladimir Yakushev, the Governor of the region Vadim Shumkov and Senator Sergey Muratov, Denis Manturov got acquainted with the production of NPO Kurganpribor and appreciated the exhibition where the products of the leading enterprises of the city were presented.
The pharmaceutical plant "Velpharm" presented at the exhibition more than 60 drugs, many of which are produced within the framework of the project "Counteracting Epidemic Diseases: Production of Antiviral Drugs, Expanding the Production of Drugs Relieving the Symptoms of the Disease", developed by the Ministry of Health of the Russian Federation and supported by the Industrial Development Fund of the Russian Federation (Moxifloxacin Velpharm, Azithromycin, Vitridinol, Heparin sodium, Velferrum, Veldeksal and others).
Vladimir Yakushev noted that, thanks to the work of the region's pharmaceutical enterprises, there is currently no shortage of drugs used in the treatment of coronavirus infection in the Ural Federal District. During the working meeting, the successes of the Trans-Ural enterprises in creating new jobs and increasing labor productivity were also noted.
 BRIGHT WAY GROUP invites you to visit our stand at the International Exhibition and Forum on Pharmaceuticals and Biotechnology PhEB Russia, St. Petersburg

BRIGHT WAY GROUP invites you to visit our stand at the International Exhibition and Forum on Pharmaceuticals and Biotechnology PhEB Russia, St. Petersburg

More details

Velpharm LLC is on the first line in the rating of leading corporations in terms of growth in the retail commercial drug market

More details